Objective
The ultimate goal of our Consortium is to generate the necessary data to allow xenotransplantation to progress towards its initial clinical phase. The data generated during this project will encompass both efficacy and safety aspects of xeno-transplantation. Tools that will be used to reach this ambitious objective encompass state-of-the-art biomolecular technologies and in vivo models. XENOME aims to produce a "super-engineered" pig, i.e. a pig with a newly generated genotype that will improve the efficacy and safety profile of xenotransplantation. Assessments of efficacy will first take advantage of existing pig lines expressing human complement regulators, thrombomodulin (TM) and knock-out for a-Gal transferase. Using the most suitable background, further engineering will eliminate one or more PERV sequences. Additional transgenes, such as HO-1, CD39 and other molecules able to control immune responses, endothelial cell activation and subsequent microangiopathy, will be added.
The ultimate pig strain will thus combine the already available background with novel molecules exhibiting anti-inflammatory, anticoagulant and immunosuppressive properties. In addition, an effective immuno-suppression regimen will be defined and new pharmaceutical agents will be tested. A strong safety framework will also be established that may allow, at some stage, progression of xenotransplantation into the clinic. This will involve development of technologies enabling the timely diagnosis of infection, design of a safety plan for an efficacious containment of an untoward infectious event, breeding of a herd of "clean" source pigs, inactivation of PERV sequences and provide safety-related data deriving from long-term in vivo studies in primate xenograft recipients. Finally, the project will also provide a strong ethical, social (especially regarding public communication) and regulatory framework for xenotransplantation research (and possibly clinical application).
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciencesbiological scienceszoologymammalogyprimatology
- medical and health sciencesbasic medicineimmunology
- natural sciencesbiological sciencesgeneticsgenomes
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback.
You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Call for proposal
FP6-2005-LIFESCIHEALTH-6
See other projects for this call
Funding Scheme
IP - Integrated ProjectCoordinator
PADOVA
Italy
See on map
Participants (25)
TORQUAY
See on map
NANTES
See on map
LEIOA (BIZKAIA)
See on map
VIENNA
See on map
LONDON
See on map
NEUSTADT
See on map
GLASGOW
See on map
LA SERRA DI SAN MINIATO (PI)
See on map
PRAGUE
See on map
30623 HANNOVER
See on map
PADUA
See on map
CAMBRIDGE
See on map
KONSTANZ
See on map
PADOVA
See on map
UPPSALA
See on map
COIMBRA
See on map
LISBOA
See on map
9600 LEIDEN
See on map
GLASGOW
See on map
PARIS
See on map
GREIFSWALD, INSEL RIEMS
See on map
CREMONA
See on map
MILANO
See on map
MILAN
See on map
OTTIGNIES LOUVAIN-LA-NEUVE
See on map